Greenleaf Trust’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-12,944
| Closed | -$1.13M | – | 815 |
|
|
2025
Q2 | $1.13M | Sell |
12,944
-4,265
| -25% | -$334K | 0.01% | 295 |
|
|
2025
Q1 | $1.18M | Buy |
17,209
+3,114
| +22% | +$254K | 0.01% | 287 |
|
|
2024
Q4 | $1.1M | Buy |
14,095
+2,255
| +19% | +$167K | 0.01% | 300 |
|
|
2024
Q3 | $794K | Sell |
11,840
-2,671
| -18% | -$219K | 0.01% | 394 |
|
|
2024
Q2 | $1.65M | Buy |
14,511
+455
| +3% | +$57.5K | 0.02% | 205 |
|
|
2024
Q1 | $1.95M | Buy |
14,056
+7,645
| +119% | +$961K | 0.02% | 186 |
|
|
2023
Q4 | $796K | Buy |
6,411
+1,761
| +38% | +$180K | 0.01% | 332 |
|
|
2023
Q3 | $434K | Sell |
4,650
-568
| -11% | -$64K | 0.01% | 474 |
|
|
2023
Q2 | $671K | Sell |
5,218
-55
| -1% | -$6.65K | 0.01% | 377 |
|
|
2023
Q1 | $613K | Sell |
5,273
-196
| -4% | -$21.9K | 0.01% | 393 |
|
|
2022
Q4 | $619K | Buy |
5,469
+1,714
| +46% | +$188K | 0.01% | 384 |
|
|
2022
Q3 | $302K | Buy |
+3,755
| New | +$318K | ﹤0.01% | 534 |
|
|
2022
Q2 | – | Sell |
-3,720
| Closed | -$476K | – | 736 |
|
|
2022
Q1 | $476K | Buy |
3,720
+492
| +15% | +$53.8K | 0.01% | 435 |
|
|
2021
Q4 | $433K | Buy |
3,228
+212
| +7% | +$30.5K | 0.01% | 469 |
|
|
2021
Q3 | $412K | Buy |
3,016
+472
| +19% | +$59.5K | 0.01% | 462 |
|
|
2021
Q2 | $272K | Sell |
2,544
-28
| -1% | -$2.69K | ﹤0.01% | 612 |
|
|
2021
Q1 | $231K | Buy |
+2,572
| New | +$241K | ﹤0.01% | 645 |
|
|
2018
Q2 | – | Sell |
-668
| Closed | -$12K | – | 532 |
|
|
2018
Q1 | $12K | Hold |
668
| – | – | ﹤0.01% | 524 |
|
|
2017
Q4 | $10K | Sell |
668
-372
| -36% | -$4.83K | ﹤0.01% | 656 |
|
|
2017
Q3 | $13K | Buy |
+1,040
| New | +$18.4K | ﹤0.01% | 639 |
|
Other funds holding DXCM
N
